My colleagues at Memorial Sloan Kettering Cancer Center developed a mouse model for thyroid cancer in order to study the effect of the BRAF driver oncogene on a molecular basis and its role in creating the tumor phenotype. This evidence concerns the gene BRAF and thyroid cancer.